Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In proliferative diseases of the homeopathic system before starting and at the end of treatment, the values of 8 acute phase factors were studied simultaneously, that is: seromucoid, sialic acid, alpha 1 acid glycoprotein, alpha 1 antitrypsin, haptoglobin,
ceruloplasmin
, transferrin, and fibrinogen. In chronic myeloid and lymphatic leukaemia no constant increase nor decrease of the concentration of any of the factors was found. In non-Hodgkin lymphoma the concentration of one factor -
ceruloplasmin
was constantly increased, and that of two factors--sialic acid and fibrinogen was decreased, while in plasmocytoma the concentration of two factors--haptoglobin and
ceruloplasmin
was constantly increased. At the end of treatment the concentration of certain factors was changing. In
chronic myeloid leukaemia
the concentration of
ceruloplasmin
, fibrinogen, and seromucoid was decreasing, while in non-Hodgkin lymphoma the concentration of haptoglobin and fibrinogen was increasing, in chronic lymphatic leukaemia the concentration of haptoglobin and increasing, in chronic lymphatic leukaemia the concentration of haptoglobin and transferrin was increasing, and in plasmocytoma the concentration was increasing of haptoglobin, sialic acid, and transferrin. The result of treatment in
chronic myeloid leukaemia
was good, in non-Hodgkin lymphoma and chronic lymphatic leukaemia--moderate, and in plasmocytoma it was least beneficial.
...
PMID:[Factors of the "acute phase" in proliferative diseases of the hemopoietic system]. 129 50
The investigation of cell composition and different biochemical parameters (
ceruloplasmin
, lactate dehydrogenase, aldolase, ferritin, beta-2-microglobulin) in cerebrospinal fluid has been performed in 37 patients with
chronic myeloid leukemia
at different clinicohematological stages. The age of the patients ranged from 16 to 67 years. CNS involvement has been diagnosed in 8 (21.6%) patients by clinical and cytological criteria and in 5 (13.5%) patients on the basis of changes in liquor cytograms and in biochemistry. Morphological substrate of leukemic infiltration may be represented by blast cells and cells of granulocytic line of all stages of differentiation. Direct correlation has been established between ferritin and beta-2-microglobulin levels in liquor and its cytological patterns. This permits a conclusion on possible usage of liquor concentration of beta-2-microglobulin and ferritin measurements as additional tests in the diagnosis of neuroleukemia in
chronic myeloid leukemia
.
...
PMID:[The cytological and biochemical aspects of studying the cerebrospinal fluid in patients with chronic myeloleukemia]. 821 76
We investigated the role of
ceruloplasmin
in the antioxidative process in the brain in a patient with hereditary
ceruloplasmin
deficiency (HCD). Immunohistochemistry revealed an accumulation of Nepsilon-(carboxymethyl) lysine (
CML
) in basal ganglia of the HCD brain. In vitro study disclosed that
ceruloplasmin
inhibited
CML
formation from glycated proteins through the reaction of Fe2+ with H2O2 by Fenton reaction. These data suggest that
ceruloplasmin
plays an important role in the protection of neurons against oxidative stress associated with iron metabolism.
...
PMID:Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain. 1044 2